Rapafusyn Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Rapafusyn Pharmaceuticals obtains the rights to use technology associated with a unique type of macrocycle that resembles natural products. The company creates new medications to help individuals with various illnesses and address unmet medical needs.
Rapafusyn Pharmaceuticals has raised $28.0M across 1 funding round on record, the most recent a Series A of $28.0M announced in Jun 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rapafusyn Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Rapafusyn Pharmaceuticals Funding Rounds
Rapafusyn Pharmaceuticals Founders and Leadership Team
Contact details for the Rapafusyn Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Rapafusyn Pharmaceuticals Funding Compared to Other Biotechnology Startups
Rapafusyn Pharmaceuticals' latest round of $28.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rapafusyn Pharmaceuticals in Biotechnology and Baltimore
Companies Similar to Rapafusyn Pharmaceuticals
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Rapafusyn Pharmaceuticals Funding FAQs
What does Rapafusyn Pharmaceuticals do?
Rapafusyn Pharmaceuticals obtains the rights to use technology associated with a unique type of macrocycle that resembles natural products. The company creates new medications to help individuals with various illnesses and address unmet medical needs.
How much funding has Rapafusyn Pharmaceuticals raised?
Rapafusyn Pharmaceuticals has raised $28.0M across 1 round on record. The most recent is a Series A of $28.0M announced in Jun 2024.
When did Rapafusyn Pharmaceuticals last raise funding?
Rapafusyn Pharmaceuticals' most recent funding round on record is a Series A of $28.0M, announced in Jun 2024.
Who founded Rapafusyn Pharmaceuticals?
FundedIQ lists Sean X Hu (Founder) at Rapafusyn Pharmaceuticals.
Where is Rapafusyn Pharmaceuticals headquartered?
Rapafusyn Pharmaceuticals is based in Baltimore, Maryland, United States.
How many employees does Rapafusyn Pharmaceuticals have?
Rapafusyn Pharmaceuticals is in the 11-50 employee band.
How does Rapafusyn Pharmaceuticals' funding compare to other Biotechnology startups?
Rapafusyn Pharmaceuticals' latest round of $28.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Rapafusyn Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rapafusyn Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.